Q4 2020 Holdings
Filed 2021-02-16 | 59 holdings | $344.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $272.1M | 3,156,981 | 79.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $21.6M | 1,920,500 | 6.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $15.8M | 477,928 | 4.6% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $14.3M | 300,000 | 4.1% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $12.1M | 300,000 | 3.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.0M | 159,622 | 1.2% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $4.0M | 123,465 | 1.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $180.0K | 3,743,875 | 0.1% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $103.4K | 1,682,178 | 0.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $48.9K | 1,400,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $44.2K | 850,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $33.7K | 1,604,392 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $32.5K | 947,873 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $31.7K | 450,000 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $23.2K | 676,894 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $22.7K | 569,602 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $19.9K | 430,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $17.2K | 300,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $17.1K | 200,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $17.1K | 671,454 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $16.8K | 606,548 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $15.3K | 715,000 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $13.9K | 300,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $13.2K | 150,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $12.2K | 120,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.0K | 50,000 | 0.0% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $10.1K | 300,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $9.8K | 1,200,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $9.3K | 490,000 | 0.0% |
| Miragen Therapeutics Inc | COM NEW | 60463E202 | $9.0K | 550,000 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $8.8K | 344,438 | 0.0% |
| Vincera Pharma Inc | UNIT 12/24/2025 | 92731L205 | $7.7K | 400,000 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.6K | 230,297 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $7.0K | 500,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $6.9K | 110,920 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $6.6K | 550,000 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $6.4K | 121,562 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $6.2K | 100,000 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $5.2K | 75,000 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $4.6K | 699,999 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.8K | 300,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.7K | 140,000 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $3.6K | 100,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT 99/99/9999 | 110122157 | $3.5K | 5,050,000 | 0.0% |
| Novus Therapeutics Inc | COM | 67011N204 | $3.5K | 224,071 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $3.4K | 100,000 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $2.8K | 50,000 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $2.6K | 200,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $2.3K | 200,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.3K | 200,000 | 0.0% |